<DOC>
	<DOCNO>NCT00188825</DOCNO>
	<brief_summary>The study evaluate efficacy safety basiliximab Vs placebo induction therapy combine standard triple immunosuppression therapy , prevention acute rejection episodes prevention Bronchiolitis Obliterans Syndrome .</brief_summary>
	<brief_title>Study Comparing Simulect Plus Standard Immunosuppression Standard Immunosuppression Alone Prevention Acute Rejection Bronchiolitis Obliterans Lung Transplant</brief_title>
	<detailed_description>The objective study evaluate efficacy safety basiluximab prevention acute allograft lung rejection use addition Neoral , corticosteroid azathioprine . Acute rejection episode evaluate first 6 month post-transplant . Bronchiolitis obliterans syndrome ( BOS ) evaluate end 1 year transplant additional follow-up visit 2 3 year transplant .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<criteria>Inclusion criterion Male female recipient first bilateral single lung lobar allograft suitable receive Neoral/ corticosteroids/ azathioprine/ Basiliximab ( Simulect ) . Patients great 18 year age . Patients capable understanding purpose risk study give informed write consent . Patients require immunosuppressive therapy study medication . Patients participate another ( investigational ) drug trial participate study within 30 day prior transplantation . Pregnant mother , nurse woman . Women unwilling use adequate contraception 3 month receive study drug . Patients receive require investigational drug , except antibiotic . Patients current past peak panel reactive antibody level 25 % great . Patients malignancy history malignancy successfully treat nonmetastatic basal cell squamous cell carcinoma skin . Patients form substance abuse psychiatric disorder , opinion investigator , might invalidate patient communication clinician ( ) . Patients previously receive Simulect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Lung</keyword>
	<keyword>Transplant</keyword>
	<keyword>Rejection</keyword>
	<keyword>BOS</keyword>
</DOC>